Literature DB >> 22778870

The top prescription drugs of 2010 in the United States: antipsychotics show strong growth.

Craig W Lindsley.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22778870      PMCID： PMC3369734          DOI： 10.1021/cn200050c

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN： 1948-7193            Impact factor:   4.418


× No keyword cloud information.
  1 in total

1.  The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2010-06-16       Impact factor: 4.418
  1 in total
  6 in total

1.  2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-08-21       Impact factor: 4.418

2.  The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-06-19       Impact factor: 4.418

3.  The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418

4.  2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2014-04-16       Impact factor: 4.418

5.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

6.  Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.

Authors:  Yuan Ji; Daniel J Schaid; Zeruesenay Desta; Michiaki Kubo; Anthony J Batzler; Karen Snyder; Taisei Mushiroda; Naoyuki Kamatani; Evan Ogburn; Daniel Hall-Flavin; David Flockhart; Yusuke Nakamura; David A Mrazek; Richard M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.